Published in Ann Rheum Dis on August 01, 1976
Cutaneous and ocular reactions to practolol. Br Med J (1974) 8.65
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest (1972) 4.80
Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J (1975) 3.33
Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med (1967) 3.29
Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Br Med J (1975) 3.12
Cell surface markers for human T and B lymphocytes. Eur J Immunol (1974) 2.70
Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58
IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes. J Immunol (1975) 1.97
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum (1975) 1.39
Effect of adrenergic compounds, aminophylline and hydrocortisone, on in vitro immunoglobulin synthesis by normal human peripheral lymphocytes. J Allergy Clin Immunol (1973) 0.94
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Circadian variation of blood-pressure. Lancet (1978) 5.22
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet (1993) 3.08
Acute subvalvar mitral incompetence. Lancet (1966) 2.65
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
First myocardial infarctions in Asian and white men. BMJ (1989) 2.40
Mumps meningitis and measles, mumps, and rubella vaccine. Lancet (1992) 2.30
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise. Lancet (1980) 2.05
Total body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet (1975) 2.01
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Haemodynamic effects of long-term oral labetalol. Br J Clin Pharmacol (1976) 1.78
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother (1974) 1.76
Combined therapy with verapamil and propranolol in chronic stable angina. Am J Cardiol (1982) 1.75
Ambulatory electrocardiographic records in patients with transient cerebral attacks or palpitation. Br Med J (1975) 1.71
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Incidence and management of supraventricular arrhythmias after acute myocardial infarction. Lancet (1967) 1.62
Relationship between plasma cholesterol and coronary artery disease in Asians. Atherosclerosis (1990) 1.61
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Infection of left ventricular thrombus in a patient with silent myocardial infarction--a unique complication. Eur Heart J (1993) 1.54
Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet (1987) 1.54
The over-shoot phenomenon on withdrawal of clonidine therapy. Postgrad Med J (1976) 1.54
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise. J Hypertens (1983) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Is the blood pressure the same in both arms? Clin Cardiol (1985) 1.47
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
The methodology of blood pressure recording. Br J Clin Pharmacol (1978) 1.42
Disturbances of insulin in British Asian and white men surviving myocardial infarction. BMJ (1989) 1.41
Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension. Clin Nephrol (1989) 1.40
Ambulatory ST segment monitoring. Problems, pitfalls, solutions, and clinical application. Br Heart J (1980) 1.39
Ventricular tachycardia induced by Valsalva's manoeuvre in a patient with hypertrophic cardiomyopathy. Int J Cardiol (1988) 1.39
Early diagnosis of acute myocardial infarction with use of a rapid immunochemical assay of creatine kinase MB isoenzyme. Clin Chem (1993) 1.38
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Multilocus markers for mouse genome analysis: PCR amplification based on single primers of arbitrary nucleotide sequence. Mamm Genome (1992) 1.36
A study of the antihypertensive action of xipamide using ambulatory intra-arterial monitoring. Br J Clin Pharmacol (1981) 1.35
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
The Oxford continuous blood-pressure recorder--technical and clinical evaluation. Postgrad Med J (1976) 1.33
Tape monitoring of the electrocardiogram in ambulant patients with sinoatrial disease. Br Heart J (1973) 1.31
Transcutaneous aortovelography. A quantitative evaluation. Br Heart J (1976) 1.30
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens. J Viral Hepat (2006) 1.28
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Blood pressure and heart rate and withdrawal of antihypertensive drugs. Br Med J (1977) 1.27
The indirect method of recording blood pressure. Cardiovasc Res (1968) 1.25
Validation of beat by beat pulsed Doppler measurements of ascending aortic blood velocity in man. Cardiovasc Res (1987) 1.23
Who is being tested for genital chlamydia in primary care? Sex Transm Infect (2003) 1.23
Circadian variation of blood pressure in autonomic failure. Circulation (1983) 1.23
Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm Res (1996) 1.22
Effect of once-daily atenolol on ambulatory blood pressure. Br Med J (1979) 1.22
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
Use of graded exercise testing in assessing the hypertensive patient. Clin Cardiol (1980) 1.18
Relation of human cardiac action potential duration to the interval between beats: implications for the validity of rate corrected QT interval (QTc). Br Heart J (1987) 1.17
Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment. Br J Clin Pharmacol (1981) 1.16
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Ventricular fibrillation threshold of healthy dogs to 50Hz current in relation to earth leakage currents of electromedical equipment. Biomed Eng (1972) 1.14
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Discovery of cryptophycin-1 and BCN-183577: examples of strategies and problems in the detection of antitumor activity in mice. Invest New Drugs (1997) 1.12
Mechanisms of production of heart sounds based on records of sounds after valve replacement. Am J Cardiol (1966) 1.12
Left ventricular function during isometric hand grip and cold stress in normal subjects. Br Heart J (1986) 1.11
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Radionuclide left ventricular ejection fraction: a comparison of three methods. Br Heart J (1987) 1.10
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. Am J Cardiol (1981) 1.08
Specialized gastrointestinal units for the management of upper gastrointestinal haemorrhage. Postgrad Med J (1990) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Exercise-induced ST segment elevation. Electrocardiographic, angiographic, and scintigraphic evaluation. Br Heart J (1980) 1.08
Disturbances of heart rhythm produced by 50 Hz leakage currents in dogs. Cardiovasc Res (1975) 1.07
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
The infrasound blood-pressure recorder. A clinical evaluation. Lancet (1976) 1.07
Propranolol LA and ambulatory blood pressure. Br J Clin Pharmacol (1980) 1.07
Radionuclide measurements of diastolic function for assessing early left ventricular abnormalities in the hypertensive patient. Br Heart J (1988) 1.06
Myocardial ischaemia in patients with frequent angina pectoris. Br Med J (1979) 1.05
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04
Once daily treatment of mild to moderate hypertension with xipamid: a controlled study. Br J Clin Pharmacol (1977) 1.03
Haemostatic variables and the outcome of myocardial infarction. Thromb Haemost (1983) 1.03
Ambulant blood pressure: reproducibility and the assessment of interventions. Clin Sci (Lond) (1980) 1.03
Study of untreated hypertensive subjects by means of continuous intra-arterial blood pressure recordings. Br Heart J (1978) 1.03
A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris. Br J Clin Pharmacol (1980) 1.03
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice. Invest New Drugs (1997) 1.02
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Clinical significance of the coronary arteriogram. Br Heart J (1971) 1.00
Mechanical performance of Hammersmith mitral valve prosthesis. Br Heart J (1968) 1.00
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension. Lancet (1976) 0.99
Incidence and management of ventricular arrhythmias after acute myocardial infarction. Br Heart J (1969) 0.98